Načítá se...
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Chimeric antigen receptor (CAR) T cell therapy for hematologic malignancies is fraught with several unknowns, including number of functional T cells that engage target tumor, durability and subsequent expansion and contraction of that engagement, and whether toxicity can be managed. Non-invasive, se...
Uloženo v:
| Vydáno v: | Sci Adv |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association for the Advancement of Science
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609218/ https://ncbi.nlm.nih.gov/pubmed/31281894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaw5096 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|